Is hepatic neoplasm-related pyogenic liver abscess a distinct clinical entity?

Table 4 Management and outcomes of pyogenic liver abscess with/without hepatic neoplasm n (%)

	HN group(n = 35)	Non-HN group(n = 283)	P value
Intervention
Imaging-guided aspiration ± drainage	27 (77.1)/ 6 (17.1)	233 (82.3)/ 206 (72.8)	0.23/ < 0.01
Surgical drainage	1 (2.9)	18 (6.4)	0.20
Complications and outcomes
Metastatic infection	0 (0)	17 (5.7)	0.07
Septic shock	14 (40)	77 (27.2)	0.06
DIC1	6 (17.1)	44 (15.5)	0.39
Acute coronary syndrome	2 (5.7)	14 (4.9)	0.42
Respiratory/renal failure	1 (2.9)	14 (4.9)	0.29
ICU care2	1 (2.9)	31 (11)	0.07
Recurrence	1 (2.9)	16 (5.7)	0.25
Death	25 (71.4)	25 (8.8)	< 0.01

¹For disseminated intravascular coagulation;

²For intensive care unit. HN: Hepatic neoplasm.